ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

2.48
Delayed Data
As of Mar 27
 -0.22 / -8.15%
Today’s Change
1.80
Today|||52-Week Range
7.25
-47.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization138.0K157.0K163.0K140.0K
 
 
 
 
 
 
Operating ExpensesGross Income-138.0K-157.0K-163.0K-140.0K
 
 
 
 
 
General Expenses12.2M12.4M12.6M13.5M
 
 
 
 
 
Research And Development7.5M8.3M8.2M9.5M
 
 
 
 
 
Total Operating Expenses12.4M12.6M12.8M13.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-12.6M-12.8M-13.6M
 
 
 
 
 
Extraordinary Credit183.0K--113.0K0.00
 
 
 
Extraordinary Charge0.00-165.0K0.000.00
 
 
Other Expenses164.0K150.0K168.0K187.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-12.6M-12.5M-13.4M
 
 
 
 
 
Preferred Dividend-5.5M-6.1M-342.0K0.00
 
 
 
 
Extraordinary Items0.000.00207.4M0.00
 
 
Net Income-12.0M-12.6M-12.5M-13.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS141.0M141.2M150.9M160.6M
 
 
 
 
 
Shares To Calculate EPS Diluted141.0M141.2M150.9M160.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.13$1.29-$0.08
 
 
 
 
 
EPS Diluted-$0.12-$0.13-$0.09-$0.08